ASCULOGENESIS, the formation of blood vessels by V in situ differentiation of endothelial cells from their angioblastic precursors, is one of the fundamental process leading to the development of a primary vasculature in the embryo. During murine embryogenesis, angioblasts are known to arise from differentiation of mesodermal cells at early developmental stages. This occurs shortly after gastrulation both in the embryo proper, where angioblasts are first detected within paraxial and lateral plate mesoderm as early as stage E7.0, and within the yolk sac extraembryonic niesoderm between E7.5 and E8.5, where they constitute the outer layer of blood islands.',' These angioblasts then differentiate and connect into a primitive vascular plexus that can expand and mature into blood v e~s e l s .~.~ However, maturation stages and molecular mechanisms involved in the regulation of vasculogenesis remain to be characterized. Studies aimed at defining the molecular events and growth factors involved in the establishment of the vascular system have been hampered by the relative inaccessibility of the endothelial precursors at early stages of development. To overcome this problem, there is the need for in vitro model systems that would duplicate the events involved in establishing the early vascular system in vivo. Murine embryonic stem (ES) cell lines have been previously established from the inner cell mass of mouse blastocysts and have been shown to have the potential to generate all embryonic cell lineages when they undergo differentia- The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.
Embryonic Stem Cells Differentiate In Vitro to Endothelial Cells Through Successive Maturation Steps
By Daniel Vittet, Marie-Helene Prandini, Rolande Berthier, Annie Schweitzer, Herve Martin-Sisteron, Georges Uzan, and Elisabetta Dejana
The mechanisms involved in the regulation of vasculogenesis still remain unclear in mammals. Totipotent embryonic stem (ES) cells may represent a suitable in vitro model t o study molecular events involved in vascular development. In this study, we followed the expression kinetics of a relatively large set of endothelial-specific markers in ES-derived embryoid bodies (EBs). Results of both reverse transcriptionpolymerase chain reaction and/or immunofluorescence analysis show that a spontaneous endothelial differentiation occurs during EBs development. ES-derived endothelial cells express a full range of cell lineage-specific markers: platelet endothelial cell adhesion molecule (PECAM), Flk-1, tie-1, tie-2, vascular endothelial (VE) cadherin, MECA-32, and MEC-14. 7 . Analysis of the kinetics of endothelial marker expression allows the distinction of successive maturation steps. Flk-I was the first t o be detected; its mRNA is apparent from ASCULOGENESIS, the formation of blood vessels by V in situ differentiation of endothelial cells from their angioblastic precursors, is one of the fundamental process leading to the development of a primary vasculature in the embryo. During murine embryogenesis, angioblasts are known to arise from differentiation of mesodermal cells at early developmental stages. This occurs shortly after gastrulation both in the embryo proper, where angioblasts are first detected within paraxial and lateral plate mesoderm as early as stage E7.0, and within the yolk sac extraembryonic niesoderm between E7.5 and E8.5, where they constitute the outer layer of blood islands.',' These angioblasts then differentiate and connect into a primitive vascular plexus that can expand and mature into blood v e~s e l s .~.~ However, maturation stages and molecular mechanisms involved in the regulation of vasculogenesis remain to be characterized. Studies aimed at defining the molecular events and growth factors involved in the establishment of the vascular system have been hampered by the relative inaccessibility of the endothelial precursors at early stages of development. To overcome this problem, there is the need for in vitro model systems that would duplicate the events involved in establishing the early vascular system in vivo. Murine embryonic stem (ES) cell lines have been previously established from the inner cell mass of mouse blastocysts and have been shown to have the potential to generate all embryonic cell lineages when they undergo differentia-day 3 of differentiation. PECAM and tie-2 mRNAs were found t o be expressed only from day 4, whereas VE-cadherin and tie-1 mRNAs cannot be detected before day 5. Immunofluorescence stainings of EBs with antibodies directed against Flk-1, PECAM, VE-cadherin, MECA-32, and MEC-14.7 confirmed that the expression of these antigens occurs at different steps of endothelial cell differentiation. The addition of an angiogenic growth factor mixture including erythropoietin, interleukin-6, fibroblast growth factor 2, and vascular endothelial growth factor in the EB culture medium significantly increased the development of primitive vascular-like structures within EBs. These results indicate that this in vitro system contains a large part of the endothelial cell differentiation program and constitutes a suitable model t o study the molecular mechanisms involved in vasculogenesis. t i~n .~ ES cells can be maintained in their pluripotential state if cultured in the presence of leukemia inhibitory factor (LIF), which inhibits their differentiation. When LIF is removed, ES cells spontaneously differentiate into cyst-like structures, termed embryoid bodies (EBs), which contain derivatives of the three primitive germ layer^.^ The appearance of blood island-like structures that consist of immature hematopoietic cells surrounded by endothelial cells and the formation of vascular-like channels have been reported on the surface of cystic EBs, suggesting that ES cells produce all the factors necessary for the induction of vasculogenesis.' ' However, in these early studies, the characterization of vascular development in EBs has been made difficult by the lack of a large set of specific markers.
In this report, we followed the expression of different and recently characterized endothelial cell-specific molecules during the formation of vascular structures in ES-derived EBs. The markers considered include growth factor receptors (Flk-1 ,I".' tie-I, and tie-2'*,''); adhesive molecules such as vascular endothelial (VE) cadherin,14 and platelet endothelial cell adhesion molecule (PECAM)"; and other endothelialspecific antigens such as MECA-32" and MEC-14.7. Our data indicate that differentiating ES cells can acquire the all range of markers. The appearance of endothelial-specific molecules occurred at different times after the onset of ES cell differentiation, recapitulating in vivo vasculogenesis steps and suggesting that, similarly to hematopoiesis, endothelial cell commitment follows sequential maturation stages.
MATERIALS AND METHODS
Three 129/Sv-derived ES cell lines were used throughout the experiments. CCE" and CJ7" cell lines were maintained undifferentiated without feeder layer on gelatin-coated tissue culture dishes in the presence of lo3 U/mL LIF.'",2" The LIF was obtained from supernatants of cos-7 transfected cells with pCI0-6R plasmid containing the cDNA from human LIF." R1 22 cells were maintained undifferentiated on confluent feeder layers of mitomycin C-treated primary embryonic fibroblasts. '3 To initiate ES cell differentiation and EBs formation, trypsinized ) were plated in semisolid 1 % methylcellulose-containing medium, as previously described." The day of trypsinization was considered to be day 0 of differentiation. ES cells (1.25 X IO3 cells/mL or 2.5 X lo3 cells/mL according to the time length of the culture) were seeded in a final volume of 2.0 mL in 35-mm bacterial grade petri dishes (Greiner, Frickenhausen, Germany). Cultures were maintained without further feeding for up to 11 days, EBs were collected at different days of differentiation, after dilution of the semisolid methylcellulose medium with phosphate-buffered saline solution (PBS).
When indicated, the methylcellulose medium was further supplemented with growth factors. All factors were added at the initiation of the culture and they were used at concentrations that are known to give maximal biologic activities. Recombinant human vascular endothelial growth factor (VEGF Peprotech Inc, Canton, MA) was used at SO ng/mL, mouse erythropoietin (EPO; Boehringer Mannheim, Mannheim, Germany) was used at 2 U/mL, human basic fibroblast growth factor (FGF2; Genzyme, Cambridge, MA) was used at 100 ng/mL, and murine interleukin-6 (IL-6; Genzyme) was used at 10 ng/mL.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis. Total RNAs from undifferentiated ES cells and from embryoid bodies were isolated using a microscale rapid total RNA isolation kit (5 Prime-3 Prime, Inc, Boulder, CO). First-strand cDNAs were generated, after treatment of RNA with RQ1 DNase (Promega, Charbonnitres, France), using Moloney murine leukemia virus (MMLV) reverse transcriptase (GIBCO, Grand Island, NY) and random hexamer primers (Pharmacia Biotech SA, St Quentin Yvelines, France) under conditions recommended by the manufacturers. Control reactions without reverse transcriptase were performed for each RNA sample.
For the PCR reaction, first-strand cDNAs (the equivalent of 50 ng reverse-transcribed RNA) were amplified in a final volume of 20 pL with 0.5 U Taq DNA polymerase (Boehringer Mannheim) and 20 pmol of each nucleotide primer. The amplification parameters were 94°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute for 25 or 30 cycles, followed by 5 minutes at 72°C for final extension.
All PCR experiments included reverse transcriptase negative controls and a blank with no template. To improve the sensitivity of the detection and to check for the specificity of the PCR reaction, the amplified products were subjected to Southern blotting and were hybridized with [32P]-5'-end-labeled intemal oligonucleotide probes specific for respective amplification product, according to standard protocols.z4 The oligonucleotide primers and probes that were used are listed in Table 1 . To ensure semiquantitative results of the RT-PCR assays, the number of PCR cycles for each set of primers was checked to be in the linear range of amplification. In addition, all cDNA samples were adjusted to yield equal amplification of hypoxanthine phosphoribosyltransferase (HPRT) as an internal standard. Phosphorimager quantification of HPRT amplification products showed variations of less than 20%.
EBs were embedded in OCT compound Immunocytochemistry.
(Miles Scientific, Elkhart, IN) after fixation in 4% paraformaldehyde for 1 hour at 4°C and cryoprotection in 20% (wtfvol) sucrose. Frozen sections (IO-pm thick) were mounted onto gelatin-coated glass slides, air-dried ovemight, and processed for indirect immunofluorescence microscopy. Briefly, slides were fixed for 20 minutes with 3% paraformaldehyde, permeabilized for 3 minutes with 0.5% Triton X-100, and then washed two times with PBS when experiments were performed with Flk-1 or VE-cadherin antibodies. Otherwise, slides were rehydrated for 5 minutes with PBS. They were then incubated with primary antibodies for 45 minutes. After four washes in PBS, slides were exposed for 45 minutes to a fluorescein isothiocyanate (FITC)-conjugated F(ab'), fragment of goat antirat IgG or to a tetramethyl rhodamine isothiocyanate (TR1TC)-conjugated F(ab')z fragment of goat antirabbit IgG (Jackson Immunoresearch Laboratories Inc, West Grove, PA). Both secondary antibodies were diluted 1:lOO in 2% bovine serum albumin (BSA)/PBS. After three further rinses in PBS, slides were mounted in Citifluor (Agar Scientific Ltd, Essex, UK). For double-labeling experiments, sections were incubated with a mixture of the two primary antibodies followed by incubation with a mixture of the two secondary antibodies.
Monoclonal antibodies (MoAbs) MEC-13.3, MEC-14.7, and MECA-32 were used as undiluted hybridoma supematants. Rat MoAb MEC-13.3 directed against mouse PECAM was previously characterized." Rat MoAb MEC-14.7 (kmdly provided by Dr C. Garlanda, Mario Negri Istituto, Milan, Italy) was obtained from the immunization of a Lewis rat with the mouse transformed endothelial cell line t-end.I.'* Rat MoAb MECA-32I6 was obtained from Dr R. Hallmann (Erlangen-Numberg University, Erlangen, Germany). Rabbit polyclonal antibody against mouse Flk-1 (diluted 1/200) and the corresponding control blocking peptide were purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA). Rabbit antimouse VE-cadherin antiserumz6 (diluted 11200) raised against a peptide that maps to a specific region of the murine VE-cadherin carboxy terminus was a gift from Dr D. Vestweber (Max-Plank-Institut for Immunology, Freiburg, Germany).
Flow cylometry analysis. Undifferentiated ES cells were detached or EBs dissociated by l hour of treatment at 37°C with a PBS solution containing 0.2% collagenase A (Eurobio, Les Ulis, France), 200 UlmL DNase I (Boehringer Mannheim), and 10% fetal calf serum and by repeated gentle flushing through a 21-gauge needle. Cell mortality never exceeded 15%. After two washes in PBS, aliquots containing 1 x lo6 cells were incubated at 4°C with 100 pL of a saturating concentration of antimurine PECAM MoAb for 1 hour. After two washing steps in PBS, the cells were incubated at 4°C for 1 additional hour with 100 /IL of FITC-conjugated F(ab'), fragments of goat antirat IgG (Jackson Immunoresearch Laboratories) diluted 150 in 2% BSAPBS, washed twice, and resuspended in PBS. Isotypic nonimmune rat IgG2b (10 pglmL; Pharmingen, San Diego, CA) was used as a negative control.
Quantitative fluorescence analysis was performed using a FACStar flow cytometer and the LYSIS I1 software program (Becton Dickinson, San Jost, CA). Histograms of cell number versus loga- use only.
For At the indicated time intervals, EBs were harvested and disrupted by collagenase treatment as described above. EB-derived cells were then replated in 1% methylcellulose in Iscove's modified Dulbecco's medium (IMDM; GIBCO), essentially as previously described?' in the presence of optimal concentrations of hematopoietic cytokines: 25 ng/mL murine stem cell factor (R&D Systems, Abingdon, UK), 25 ng/mL murine IL-3 (Peprotech), IO ng/mL human IL-l 1 (Peprotech), IO ng/mL human IL-6 (Genzyme), IO ng/mL human granulocyte colony-stimulating factor (G-CSF Boehringer Mannheim), 1 U/mL murine EPO (Boehringer), and 50 ng/mL human FGF2 (Genzyme). The colonies were scored under inverted light microscopy on day 6 of secondary plating.
Hematopoietic progenitor assays.

RESULTS
Kinetics qf endothelial marker expression by RT-PCR analysis. RT-PCR analysis on ES-derived EBs collected from days 3 to 7 is shown in Fig 1. Distinct gene expressions were induced at different time points during ES cell differentiation. Flk-l gene expression was found to be rapidly upregulated during EBs development, because the corresponding mRNA can be detected as soon as day 3. PECAM and tie-2 genes were found to be already expressed in undifferentiated RT-PCR analysis of gene expression in ES-derived EBS. The identity of the amplification products was established by Southern hybridization with specific internal oligonucleotide probes (see the Materials and Methods). Day 0 corresponds t o mRNA from ES cells cultured in the presence of LIF. Days 3 through 7 correspond t o days of culture after LIF deprivation. The negative control (no template) performed for each PCR reaction is shown on the right. All amplifications were performed on 50 ng cDNA for 25 cycles, with the exception of tie-1 and tie-2, which were performed for 30 cycles. We checked for each primer set that these conditions were in the nonsaturating range of PCR amplification. Shown are data from a typical experiment of two performed on CCE cells. cells. After LIF removal, transcripts of both genes first disappeared and were thereafter newly detected from day 4. Whether this mRNA loss represents transcriptional extinction of these genes or a decrease in mRNA stability remains unknown. VE-cadherin and tie-1 transcripts appeared 1 day later, ie, by day 5. After day 5, all transcripts levels remained high and consistent.
Immunofluorescent characterization of antigen expression. The time course of endothelial gene expression was also determined at the protein level by immunofluorescence studies. Consistent with the RT-PCR, PECAM immunostaining was also found on undifferentiated ES cells (results not shown). On both ES cells grown in the presence of LIF alone (CCE and CJ7) or on feeder cells (Rl), at least 40% of cells were observed by flow cytometry to be positive for PECAM, thus attesting that PECAM expression on undifferentiated ES cells was a common feature for various ES cell lines. Figure 2 reports the kinetics of appearance of the different endothelial markers during ES cell differentiation. The temporal data are also in agreement with RT-PCR results. with the exception of Flk-l and VE-cadherin staining, which appeared 1 day later than their respective mRNAs.
When looking to the distribution of these markers within EBs, we found that, when expressed, they appeared to be colocalized in the same cells. At day 4, double-labeling experiments indicated that PECAM and Flk-1 proteins were coexpressed by the same cells (Fig 3, see arrows) . VE-caduse only. herin was also found in areas stained with other endothelial markers (Fig 3, day 6) . A similar codistribution was observed with PECAM, MECA-32, and MEC-14.7 antigens in serial sections (Fig 4) . Until day 6, stainings with all markers appeared essentially concentrated in cell clusters and sometimes in poorly organized elongated processes. The development of vascular-like structures was evident by day 1 I (Fig  4, lower part) . In addition to clustered cells, both flattened and elongated processes closely resembling a primitive vascular network were stained with endothelial-specific antibodies.
Effects of growth factors on the development of endothelial cells from ES cells. To optimize the system to obtain a higher level of endothelial cell differentiation within the EBs, we added various growth factors to the culture medium. VEGF and a growth factor (GFs) cocktail including VEGF, FGF2, TL-6, and EPO were tested. These factors are known or have been postulated to be involved in the regulation of angiogenesis and/or vascular development."-" Flow cytometry quantification of PECAM-positive cells obtained from the dissociation of day 6 EBs showed that there was a significant increase in the percentage of PECAM-positive cells in the presence of VEGF or of the GFs cocktail (Fig 5A) . The GFs cocktail was also found to increase the number and size of EBs. This enhanced cellularity and number of EBs (approximately twofold higher when compared with control cultures or with cultures in the presence of VEGF alone) led to a marked increase in the absolute number of PECAM-positive cells (Fig 5B) .
PECAM is a marker found on both endothelial and hematopoietic cells.'' However, the increase in the PECAM cell population can be considered to be representative in part of early endothelial cell differentiation. Indeed, there was a considerable overlap in the expression patterns of PECAM with specific endothelial markers such as Flk-1 and MECA-32 in sections of day 6 EBs grown in these conditions (data not shown). Moreover, significant expression levels of early hematopoietic differentiation markers such as Sca-1 (Ly-6A/ E) and Thy-I were not found at this EB developmental stage (data not shown).
At later steps of development (day I I), the GFs cocktail also increased the number of PECAM-positive EBs and clearly favored the formation of vascular structures. The percentage of PECAM-positive EBs at day 1 1 was 42% 2 7% and 73% t 3% (SD, n = 3) for control and GFs cultures, respectively. Moreover, day 1 1 EBs exhibited many cordlike structures, as assessed by PECAM and VE-cadherin double-labeling experiments (Fig 6) .
On the other hand, the addition of the GFs cocktail was also observed to significantly increase hematopoietic development within ES-derived EBs, as assessed by replating disrupted EBs in conventional progenitor assays (Fig 7) .
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marked development of hematopoietic progenitors leading to all types of differentiated progeny was mainly found at day 11, concomitantly with vascular structures formation (data not shown).
DISCUSSION
In the present report, we provide further evidence that ES cells can spontaneously differentiate in vitro into the endothelial lineage, ultimately forming vascular structures in ES-derived EBs. We also obtained evidence that this process is achieved through successive endothelial developmental stages that recapitulate the initial steps of in vivo be a common and consistent feature of ES cell lines, occurring with a high frequency. Indeed, at least 30% of EBs derived from both CJ7-and CCE-ES cells were observed to have engaged a full spontaneous differentiation towards the endothelial lineage after day 8.
When looking at endothelial gene expression in undifferentiated ES cells, we found the presence of both tie-2 and PECAM. Although this finding is in agreement with previous observations for tie-2,'" it was rather unexpected for PECAM. The acquisition of these markers is unlikely to result from an uncontrolled differentiation of ES cells in LIFcontaining medium, because a large proportion of PECAMpositive cells was still observed when ES cells were grown on a feeder layer and because LIF removal induced transient disappearance of both markers. Although we cannot totally exclude that transcriptional alterations may have occurred ers appear to be coexpressed by the same cells. Interestingly, the endothelial developmental pattern observed in the ES cell culture system follows a sequence of events similar to that occuring in the embryo during the establishment of the vascular system. Indeed, the in vivo data available are consistent with those reported here for the ES cell differentiation system. During in vivo vasculogenesis, Flk-l is the earliest endothelial marker and is expressed in both extraembryonic and embryonic mesoderm at E7.0.'0.3s PECAM is detected from E7.OE7.5 at the same location as Flk-l.36 At E7.5, in the yolk sac mesenchyme from which will originate the yolk sac vasculature, the onset of tie-2'" and of VE-cadherin'" expression followed that of Flk-I. A recent detailed study on the developmental expression profiles of Flk-1, tie-2, and tie-1 also showed that these molecules were sequentially expressed at 0.5-day intervals from E7.0 to E8.0." Thereafter, the expression pattern of all these markers appeared to be very similar in the embryo vasculature.'".'"*"^^^^^ The early appearance of Flk-1 both in vitro and in vivo further supports the idea that Flk-1 occupancy by its ligand VEGF can activate the endothelial cell developmental program. Temporal and spatial expressions of both Flk-1 and VEGF correlates with vasculogenesis in the In addition, inactivation of Flk-l and VEGF genes in mice exhibits dramatic impairment of vascular structures formation..w.m Consistent with these findings, we report here that the addition of a GFs cocktail including VEGF markedly increased the development of primitive vascular-like structures within EBs.
In our cell culture system, ES cells can also undergo hematopoietic differentiation in a similar way to that found in the yolk sac and early fetal liver.41 As described by other hematopoietic progenitors arise within day-6 EBs and, at this stage, are predominantly erythroid. Similarly to the yolk sac in vivo, progenitors of the other hematopoietic cell lineages were detected later, by day 11, at the time of vascular structures assembly. All together, these results reflect a close parallel between some in vivo events and in vitro ES cell differentiation.
Spontaneous vascular differentiation from ES cells was markedly improved after the addition of angiogenic growth factors, thus allowing for the optimization of the model. Although the effect of the GFs cocktail is nonselective because an increase in hematopoiesis can also be seen and even if the reciprocal role of each cytokine in endothelial development remains to be clarified, the addition of the growth factor mixture appears to be effective in obtaining a substantial number of endothelial cells and to favor vascular structure formation in late EBs.
In conclusion, in vitro ES cell differentiation constitutes a versatile model system that could parallel the events taking place during in vivo endothelial differentiation in the embryo. Thus, this in vitro model appears useful for studying the role of single genes in the early steps of endothelial differentiation.
